Intellia Therapeutics: Excellent News from NTLA-2001 Phase 1 Clinical Trial

Intellia Therapeutics 
Intellia Therapeutics.(NTLA) and Regeneron Pharmaceuticals (REGN) today announced positive interim results from an ongoing Phase 1 clinical trial of NTLA-2001, an . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.